Omada Health, Inc. (OMDA)
NASDAQ:OMDA
Want to see OMDA full AI Analyst Report?
OMDA Stock Chart & Stats
$14.14
-$4.40(-19.47%)
At close: 4:00 PM EDT
$14.14
-$4.40(-19.47%)
Day’s Range― - ―
52-Week Range$10.28 - $26.92
Previous Close$18.29
Volume2.54M
Average Volume (3M)1.21M
Market Cap
$1.02B
Enterprise Value$813.72M
Total Cash (Recent Filing)$211.76M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.13
Next Earnings
Aug 06, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding59,448,505
10 Day Avg. Volume1,005,413
30 Day Avg. Volume1,208,586
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)4.01
Price to Sales (P/S)3.54
P/FCF Ratio54.46
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue2.87
Enterprise Value/Gross Profit4.34
Enterprise Value/Ebitda1.66K
Forecast
1Y Price Target
$22.89Price Target Upside61.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)0.28
Revenue Forecast (FY)$326.51M
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Raised GuidanceConsistent high-teens to mid-40s revenue growth and a management-led upward guidance revision reflect durable demand from employer and payer customers. A raised guide indicates sustainable contract renewals, expanding adoption, and scaling economics that support multi-quarter revenue visibility and resource planning.
Large & Growing Member BaseCrossing one million enrolled members provides scale in a subscription-style model, improving predictability and network effects. A large, growing population supports upsells, multi-condition penetration, and per-member margin gains as fixed care-team costs spread across more users over multiple quarters.
Healthy Balance Sheet & Cash GenerationA debt-free balance sheet and a multi-hundred million cash buffer give the company flexibility to invest in product, sales, and clinical trials without immediate refinancing risk. Coupled with a shift to positive operating and free cash flow, this materially lowers solvency risk over the coming 2–6 months.
Bears Say
GAAP Profitability Not Yet AchievedAlthough margins and adjusted EBITDA improved, persistent GAAP losses mean long-term return on equity remains negative absent sustained profit conversion. Continued unprofitability could force equity raises or constrain strategic investments if positive cash flow does not persist across multiple quarters.
Cohort-driven Revenue Per Member PressureRevenue step-downs as cohorts mature are an intrinsic feature of multi-year care contracts and will structurally compress blended per-member revenue unless offset by new sales, higher-value services, or price adjustments. This dynamic can temper topline growth and requires sustained new enrollment and product expansion to replace declining cohort revenue.
Competitive Multi‑Vendor PBM & Early Channel RampsNon-exclusive PBM relationships and multi-vendor channels limit pricing power and force continuous go-to-market investment to win share. Early-stage prescribing and partner ramps mean revenue from those strategic channels is backloaded, increasing execution risk and delaying structural revenue diversification.
Omada Health, Inc. News
OMDA FAQ
What was Omada Health, Inc.’s price range in the past 12 months?
Omada Health, Inc. lowest stock price was $10.28 and its highest was $26.91 in the past 12 months.
What is Omada Health, Inc.’s market cap?
Omada Health, Inc.’s market cap is $1.02B.
When is Omada Health, Inc.’s upcoming earnings report date?
Omada Health, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 49 days.
How were Omada Health, Inc.’s earnings last quarter?
Omada Health, Inc. released its earnings results on May 07, 2026. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of -$0.128 by $0.168.
Is Omada Health, Inc. overvalued?
According to Wall Street analysts Omada Health, Inc.’s price is currently Undervalued.
Does Omada Health, Inc. pay dividends?
Omada Health, Inc. does not currently pay dividends.
What is Omada Health, Inc.’s EPS estimate?
Omada Health, Inc.’s EPS estimate is 0.06.
How many shares outstanding does Omada Health, Inc. have?
Omada Health, Inc. has 59,448,505 shares outstanding.
What happened to Omada Health, Inc.’s price movement after its last earnings report?
Omada Health, Inc. reported an EPS of $0.04 in its last earnings report, beating expectations of -$0.128. Following the earnings report the stock price went down -9.634%.
Which hedge fund is a major shareholder of Omada Health, Inc.?
Currently, no hedge funds are holding shares in OMDA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Omada Health, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.89 (61.87% Upside)
$22.89 (61.87% Upside)
Blogger Sentiment
Bullish
OMDA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.70%
12-Months-Change
Fundamentals
Return on Equity
-2.81%
Trailing 12-Months
Asset Growth
114.47%
Trailing 12-Months
Company Description
Omada Health, Inc.
Omada Health is an American virtual health company that delivers evidence-based digital programs designed to manage common chronic ailments, including cardiometabolic, musculoskeletal, and behavioral health conditions, offering continuous support that bridges the gap between in-person medical appointments.
OMDA Company Deck
OMDA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong growth and improving financial health: double-digit revenue growth (42% YoY), a key membership milestone (1.025M members, +51% YoY), margin expansion (GAAP 62%, non-GAAP 64%), positive adjusted EBITDA in Q1 and an upward revision to full-year guidance. Commercial momentum was highlighted by relationships with all three large PBMs and inclusion in Optum Rx and Lilly programs, alongside differentiated clinical evidence for the GLP-1 Care Track. Near-term headwinds are mostly transitional or tactical — cohort composition pressuring blended revenue per member, early-stage nature of some prescribing channels with material revenue expected more in 2027, modest device/shipping cost pressure (~$1M) and competitive multi-vendor PBM environments. Overall, the positives materially outweigh the manageable near-term challenges.View all OMDA earnings summariesOMDA Stock 12 Month Forecast
Average Price Target
$22.89
▲(61.87% Upside)
Technical Analysis
Teladoc
―
American Well
―
GoodRx Holdings
―
Privia Health Group
―
Hinge Health, Inc. Class A
―
Ownership Overview
3.57% Insiders
14.49% Mutual Funds
44.98% Other Institutional Investors
31.16% Public Companies and
Individual Investors